Open-Label Extension Study for Subjects With H1 Antihistamine Refractory Chronic Spontaneous Urticaria Completing Study AK006-001

Clinical trial NCT06577116 · COMPLETED

Trial details

NCT number: NCT06577116
Sponsor: Allakos Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Spontaneous Urticaria

Start date: 2024-08-28
Primary completion: 2025-05-21
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.